Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 ETF (NY:IWM)

202.66 +3.15 (+1.58%)
Official Closing Price Updated: 4:10 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 ETF

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Bloomin’ Brands Stock Dives To One-Year Low After Q4 Revenue Fall: Retail Sentiment Turns Gloomy
Sentiment on Stocktwits turned ‘bearish’ compared to ‘bullish’ a week ago 
Via Stocktwits
Crucial Fibonacci Level
In this article, we shall review the latest chart of Russell 2000/RTY Futures. 
Via Talk Markets
Topics Stocks / Equities
MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’
The company significantly reduced its debt principal by $236 million, leaving just $36 million in remaining convertible debt, and ended 2024 with $203 million in cash, cash equivalents, and... 
Via Stocktwits
Nasdaq And Russell 2000 Test January Support And Go "Meh"
Not a whole lot of positivity to today, even though support held. 
Via Talk Markets
Topics Stocks / Equities
Nvidia Earnings On Deck, SMCI Regains Compliance: What's Driving Markets Wednesday?
All three major indices were green in midday trading Wednesday as the S&P 500 and Nasdaq 100 looked to snap their four-day losing streaks. NVIDIA Corp. 
Via Benzinga
Golden Ocean CEO Says Company Using Current Market Weakness To Upgrade Fleet: Retail Sentiment Hits Year-High After Q4 Beat
Revenue declined 17% year-over-year to $210.97 million but topped an analyst projection of $176.64 million. 
Via Stocktwits
Cava Group's FY25 Guidance Is 'Very Achievable,' Says Gary Black Despite Mixed Q4: 'Economic Model Is Powerful,' Says CFO
Restaurant chain owner CAVA Group reported a mixed fourth quarter and issued conservative guidance for the next fiscal year. 
Via Benzinga
Arcutis Biotherapeutics Sees 400% Spike In Retail Buzz As Q4 Beat Fuels After-Hours Rally
Sales of Zoryve, Arcutis' leading dermatology drug, surged 413% year-over-year to $69.4 million, a 55% increase from the previous quarter. 
Via Stocktwits
Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday?
Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a... 
Via Benzinga
Topics Stocks
Exposures US Equities
What Has The Market Accomplished?
Equities have taken a series of body blows in the three trading days since Wednesday’s high, the S&P 500 looked likely to make it to the end of the day yesterday and hold above its 50-day moving... 
Via Talk Markets
Topics ETFs Stocks
Exposures US Equities
Summit Therapeutics’ Retail Chatter Explodes As Pfizer Trial Pact Drowns Out Q4 Letdown
Message volume on Stocktwits jumped 2,500%, with retail traders focusing on Summit’s partnership to evaluate ivonescimab in combination with Pfizer’s antibody-drug conjugates for solid tumors. 
Via Stocktwits
You Win Some - You Lose Lots
The S&P had started to clear resistance, posting new all-time highs before sellers struck with avengence. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Palantir Extends Losses, Microsoft Slides: What's Driving Markets Monday?
The major indices struggled to maintain early momentum on Monday, but appear to climbing back with the S&P 500 and Dow Jones both green in midday trading.  
Via Benzinga
Topics Stocks
Exposures US Equities
Volatility Playbook: Key Levels And Market Catalysts To Watch Now
Markets are at a crossroads as small caps hit key support and tech shows signs of exhaustion. 
Via Talk Markets
Topics Stocks / Equities
UK's Cineworld Reportedly Eyes IPO Or Merger With AMC Or Cinemark: Retail Isn't Biting Yet
Cineworld emerged from Chapter 11 bankruptcy in mid-2023, nearly 11 months after filing for it. 
Via Stocktwits
Topics Bankruptcy Initial Public Offering
Exposures Financial Legal Securities Market
Storm Clouds And Lightning Strikes Are Rolling In Over U.S. Stocks
Nasdaq and S&P briefly hit new all-time highs before a dramatic reversal on Thursday and Friday which could be pointing to a failed breakout and double-top. 
Via Talk Markets
Topics ETFs Stocks Stocks / Equities
Exposures US Equities
The Inside Sectors Of The Economy Flash Warning
Zooming out to the weekly chart of TLT, we see a double bottom in play from the lows in October 2023 and January 2025. 
Via Talk Markets
Topics Commodities ETFs Economy
Exposures Economy
CoT: Peek Into The Future Thru Futures - How Hedge Funds Are Positioned, Feb. 23
It is tough guessing how things will shake out in the next few weeks, let alone for the remainder of the year or the next four years. If there is any certainty, it is that it will be volatile. 
Via Talk Markets
Topics Stocks / Equities
S&P 500 Goes To Red... But..
I’m sending this to you because the S&P 500 ETF (SPY​​​​​​​) has moved under its 20-day moving average and outflows have accelerated on the Russell 2000 and the S&P 500. 
Via Talk Markets
Topics ETFs Stocks Stocks / Equities
Exposures US Equities
Stock Market Indices Suffer Significant Trend Change Following Friday's Session
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness. 
Via Talk Markets
Topics ETFs Stocks / Equities
Don't Call It A Stock Market Crash
A look at what today's price action means from a technical analysis standpoint, and what you can do to be prepared for whatever the stock market throws your way. 
Via Talk Markets
Topics ETFs Stocks / Equities
CarGurus Stock Slides After Mixed Q4 Results, Weak Guidance: Retail Mood Worsens
Among key performance indicators, total paying dealers increased by 3%, and Quarterly Average Revenue per Subscribing Dealer (QARSD) gained 12% to $6,144. 
Via Stocktwits
Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism
Revenue for the quarter was $116.13 million, topping the consensus estimate of $111.16 million, driven by robust sales of its two approved drugs, Ibsrela and Xphozah. 
Via Stocktwits
Financial Markets Report For Thursday, Feb 20
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Thursday, February 20. 
Via Talk Markets
Topics Commodities Cryptocurrencies Currencies/Forex
Russell 2000 Earnings Dashboard 24Q4 - Thuersday, Feb. 20
The 24Q4 Y/Y blended earnings growth estimate is 51.5%. If the energy sector is excluded, the growth rate for the index is 81.9%. 
Via Talk Markets
Topics Stocks / Equities
S&P 500 Vs. Russell 2000: Are Small Caps Set For A Breakout?
JPMorgan analyst notes S&P 500's struggle to break past 6,100 peak. Big caps hold ground, but small caps eyeing breakout. Investors should watch key levels and global cyclical trends for implications. 
Via Benzinga
Topics Stocks
Exposures US Equities
Palantir Rally Loses Steam, Walmart Outlook Disappoints: What's Driving Markets Thursday?
Stocks tumbled Thursday, with all major indices in the red, one day after the S&P 500 notched another all-time high in Wednesday’s trading session. 
Via Benzinga
Fidelis Insurance Stock Headed Toward Worst Single-Day Decline After Disclosing Aviation Litigation, California Wildfires Impact
During Q4, the company incurred a net adverse prior-year development of $287.2 million attributable to its Aviation and Aerospace line of business. 
Via Stocktwits
Candel Therapeutics Stock Rallies On Canaccord’s Vote Of Confidence In Lead Cancer Drug: Retail Traders Rejoice
CAN-2409 could become a “best-in-class therapy” for borderline resectable pancreatic ductal adenocarcinoma, according to the analyst. 
Via Stocktwits
SpringWorks Therapeutics Gains Retail Interest Ahead Of Q4 Earnings – What Investors Expect
Recent investor enthusiasm has been fueled by reports that German healthcare giant Merck KGaA is in advanced talks to acquire SpringWorks. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.